<div class="welcome-screen" id="welcomeScreen">
  <div class="welcome-banner">
    <h1 id="welcome-title">Welcome to Chapter IV of Brain Injury Medicine!</h1>
    <p id="welcome-description">Explore the following topics to enhance your
      knowledge.</p>
  </div>

  <!-- START OF CHAPTER 14 HTML -->
<div class="explanation-card">
  <h1>Chapter 14: Prognosis and Outcome After Severe Traumatic Brain Injury (TBI)</h1>
  <h2>The Ethical Duty and Clinical Challenge of Prognostication</h2>
  <p>Clinicians caring for patients with <strong>severe TBI</strong> carry a heavy responsibility: to provide accurate, compassionate, and evidence-based prognostic information to families. This information is not a luxury. It is one of the most important needs families express following severe brain injury. Delivering prognostic insight offers families a form of <strong>cognitive control</strong>, reinforcing their trust in the medical team and reducing anxiety.</p>
  <p>In fact, many experts argue that <strong>prognostication is an ethical obligation</strong>, not merely a clinical option. Families need guidance to make informed decisions about care, rehabilitation, and expectations. Yet, physicians often <strong>avoid this task</strong>, not out of malice, but due to a combination of fears: fear of destroying hope, lack of training in delivering bad news, discomfort with probabilistic language, and an over-reliance on personal clinical experience.</p>
</div>

<div class="question-card">
  <h1>Question 1</h1>
  <p>Why is prognostic information so crucial for families after severe TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">To avoid unnecessary medical costs</li>
    <li data-answer="correct">It provides cognitive control and reduces anxiety</li>
    <li data-answer="wrong">It allows clinicians to avoid legal liability</li>
  </ul>
</div>

<div class="question-card">
  <h1>Question 2</h1>
  <p>Which of the following is NOT a commonly cited reason clinicians avoid prognostication?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Fear of extinguishing hope</li>
    <li data-answer="correct">Desire to increase research output</li>
    <li data-answer="wrong">Lack of probabilistic reasoning skills</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>From Experience to Evidence: Creating Clinical Thresholds</h2>
  <p>This chapter takes a major step forward by moving beyond anecdote and tradition. Instead, it presents an <strong>evidence-based, threshold-driven approach</strong> to TBI prognosis. Rather than vague estimations, clinicians can now use hard data to communicate likely outcomes based on specific predictor variables.</p>
  <p>The analysis draws from studies of adults with moderate to severe TBI. Predictor variables include the <strong>Glasgow Coma Scale (GCS)</strong>, <strong>length of coma</strong>, <strong>post-traumatic amnesia (PTA)</strong>, <strong>age</strong>, and <strong>neuroimaging findings</strong>. The most valuable outcome measures were those evaluated at least six months post-injury: the <strong>Glasgow Outcome Scale (GOS)</strong>, return to work, and ability to live independently.</p>
  <p>The innovative contribution of this chapter is the introduction of <strong>"threshold values"</strong>. These are cut-off points in predictor variables that dramatically alter the probability of a certain outcome. For example, when <strong>PTA exceeds 3 months</strong>, the chances of a good recovery become very unlikely. Conversely, if PTA is under 2 months, the likelihood of <strong>severe disability is minimal</strong>.</p>

  <div class="mnemonic">
    <p><strong>Mnemonic: "3-Month PTA = Poor Prognosis"</strong> — Think of PTA as a recovery clock. If it’s still ticking past 3 months, the prognosis likely stalls.</p>
  </div>
</div>

<div class="question-card">
  <h1>Question 3</h1>
  <p>What is the key advantage of using threshold values in TBI prognosis?</p>
  <ul class="options" id="options">
    <li data-answer="correct">They make outcome predictions clinically useful and concrete</li>
    <li data-answer="wrong">They eliminate the need for neuroimaging</li>
    <li data-answer="wrong">They are always accurate and definitive</li>
  </ul>
</div>

<div class="question-card">
  <h1>Question 4</h1>
  <p>According to threshold values, which of the following PTA durations is associated with a likely good outcome?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">More than 3 months</li>
    <li data-answer="correct">Less than 2 months</li>
    <li data-answer="wrong">Exactly 90 days</li>
  </ul>
</div>

<div class="question-card">
  <h1>Question 5</h1>
  <p>According to the mnemonic, what does PTA lasting longer than 3 months indicate?</p>
  <ul class="options" id="options">
    <li data-answer="correct">A poor prognosis for good recovery</li>
    <li data-answer="wrong">Imminent recovery of all functions</li>
    <li data-answer="wrong">Increased motor ability</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Predictive Power of Variables</h2>
  <p>Let us now examine the predictive utility of each variable discussed in this chapter. While <strong>no single factor</strong> is absolute, some are more powerful than others, particularly when used together.</p>
  <p>The <strong>initial GCS</strong> score is only moderately predictive. Lower scores correlate with worse outcomes, but no clear cut-off exists that strongly predicts one outcome over another. By contrast, <strong>length of coma</strong> is more telling: when coma exceeds a month, the chance of a good recovery is slim; if it's under two weeks, the risk of severe disability drops significantly.</p>
  <p><strong>PTA duration</strong> is among the most reliable indicators. Less than two months means severe disability is unlikely. More than three months means good recovery is unlikely. This variable is especially robust because it captures both cognitive and consciousness recovery.</p>
  <p>With <strong>age</strong>, older patients do worse. A good recovery is unlikely if the patient is over 65. Neuroimaging contributes valuable context: early MRI with <strong>bilateral brainstem lesions</strong> predicts poor outcomes, and CT findings like <strong>subarachnoid hemorrhage, cisternal effacement, and midline shift</strong> are associated with worse outcomes, although not determinative alone.</p>
</div>

<div class="question-card">
  <h1>Question 6</h1>
  <p>Which factor is the most consistently powerful predictor of TBI recovery?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Initial GCS</li>
    <li data-answer="correct">Post-traumatic amnesia (PTA)</li>
    <li data-answer="wrong">Epidural hematoma</li>
  </ul>
</div>

<div class="question-card">
  <h1>Question 7</h1>
  <p>Which neuroimaging finding is most strongly associated with a very poor prognosis?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Subdural hematoma</li>
    <li data-answer="correct">Bilateral brainstem lesions on early MRI</li>
    <li data-answer="wrong">Cortical contusions</li>
  </ul>
</div>
<!-- END OF CHAPTER 14 HTML -->

<!-- START OF CHAPTER 15 HTML -->
<div class="explanation-card">
  <h1>Chapter 15: Neuroimaging Correlates of Functional Outcome</h1>
  <h2>Complexity of Predicting Functional Recovery</h2>
  <p>Understanding how neuroimaging predicts function after TBI is challenging. Unlike motor or sensory deficits—where a small targeted lesion can reliably predict outcome—complex functions like memory and language are handled by widely distributed networks. A lesion seen on imaging does not always correspond to real-world impairment due to <strong>functional reorganization</strong> and individual brain variability. Neuroimaging shows structure, but not necessarily function.</p>
</div>

<div class="question-card">
  <h1>Question 8</h1>
  <p>Why is lesion-localization less reliable for predicting language outcomes?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Language relies on widely distributed brain networks</li>
    <li data-answer="wrong">Language functions always recover uniformly</li>
    <li data-answer="wrong">Language is unaffected by brain lesions</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Diffuse Brain Injury and Ventricular Enlargement</h2>
  <p>TBI often causes widespread microstructural damage that leads to macro changes: enlarged ventricles, thinning of the corpus callosum, and wider cortical sulci. The <strong>ventricle‑to‑brain ratio (VBR)</strong> quantifies generalized atrophy and correlates with poorer cognitive and behavioural outcomes. Even a quick visual check of enlarged ventricles can be informative.</p>
  <div class="mnemonic">
    <p><strong>Mnemonic: “BVS—Big Ventricles, Sad outcomes”</strong> to associate ventricular enlargement with worse prognosis.</p>
  </div>
</div>

<div class="question-card">
  <h1>Question 9</h1>
  <p>What does a high VBR suggest in TBI patients?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Better physical recovery</li>
    <li data-answer="correct">Worse cognitive and behavioural outcomes</li>
    <li data-answer="wrong">No change in prognosis</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Limitations of Imaging Modalities</h2>
  <p>Different MRI sequences (e.g., T1, T2, FLAIR, GRE) highlight different pathologies, but none show microstructure directly. This means the apparent damage may underestimate the real functional impact. Future progress depends on combining structural and functional imaging to better predict recovery outcomes.</p>
</div>

<div class="question-card">
  <h1>Question 10</h1>
  <p>Why can a small lesion on imaging still cause major deficits?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Because it may disrupt critical hubs in brain networks</li>
    <li data-answer="wrong">Because imaging always exaggerates damage</li>
    <li data-answer="wrong">Because lesion size is always mismeasured</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Regional Vulnerability Patterns</h2>
  <p>The <strong>frontal and temporal lobes</strong> are especially vulnerable to TBI due to their anatomical relationship with cranial bones. Consequently, deficits in memory and executive functions are most prevalent. Structures like the hippocampus, fornix, and mammillary body—central to memory processing—are often damaged, contributing to lasting cognitive impairment.</p>
</div>

<div class="question-card">
  <h1>Question 11</h1>
  <p>Which brain regions are most likely to be injured in TBI and lead to memory deficits?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Occipital lobes</li>
    <li data-answer="correct">Hippocampus, fornix, mammillary bodies</li>
    <li data-answer="wrong">Cerebellum</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Day‑of‑Injury (DOI) CT and Outcome Prediction</h2>
  <p>The initial CT scan is pivotal. The <strong>Marshall classification</strong> helps categorize abnormalities. While many CT findings alone aren’t strongly predictive, some are significant: <strong>brainstem lesions</strong> on DOI CT are associated with the worst functional prognosis. Combined imaging findings and PTA duration provide a better predictive model.</p>
</div>

<div class="question-card">
  <h1>Question 12</h1>
  <p>Which DOI CT finding is most strongly linked to poor prognosis?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Subarachnoid hemorrhage</li>
    <li data-answer="correct">Brainstem lesion</li>
    <li data-answer="wrong">Skull fracture</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Visual Rating by Clinicians</h2>
  <p>Clinicians can use simple visual assessments: frontal and temporal atrophy predict memory/executive deficits; white matter hyperintensities (WMHs) correlate with cognitive and mood disorders; enlarged ventricles forecast poorer outcomes; coup–contre‑coup injuries often indicate diffuse damage.</p>
</div>

<div class="question-card">
  <h1>Question 13</h1>
  <p>Which visual sign is used to estimate generalized atrophy?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Ventricular enlargement</li>
    <li data-answer="wrong">Temporal horn dilation only</li>
    <li data-answer="wrong">Cerebellar tonsil herniation</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Looking Ahead: Integration of Imaging Modalities</h2>
  <p>The future of prediction lies in combining structural imaging with functional measures—like PET, fMRI, or MRS—to bridge the gap between what is seen and what is actually happening in the brain. This layered approach aims to yield more accurate, personalized prognoses.</p>
</div>
<!-- END OF CHAPTER 15 HTML -->

<!-- START OF CHAPTER 16 HTML -->
<div class="explanation-card">
  <h1>Chapter 16: Functional Assessment in TBI Rehabilitation</h1>
  <h2>Defining Functional Assessment (FA)</h2>
  <p>Functional assessment measures how physical, cognitive, or emotional impairments affect daily life. It involves two core components: <strong>quantification</strong>—reporting a numerical value for function—and <strong>valuation</strong>—understanding the individual's personal perception of that function's meaning and importance.</p>
</div>

<div class="question-card">
  <h1>Question 14</h1>
  <p>What does ‘valuation’ refer to in functional assessment?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">A numeric score only</li>
    <li data-answer="correct">The patient’s subjective importance of a function</li>
    <li data-answer="wrong">A clinician’s observation alone</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Disablement Continuum: ICF Framework</h2>
  <p>The WHO’s ICF model guides FA. It consists of:</p>
  <ol>
    <li><strong>Impairment</strong>—body structure/function issues (e.g., GCS).</li>
    <li><strong>Activity limitation</strong>—difficulty performing tasks (e.g., FIM).</li>
    <li><strong>Participation restriction</strong>—difficulty engaging in life roles (e.g., CIQ).</li>
  </ol>
  <p>This framework clarifies that FA must target the correct level—impairment, activity, or participation—based on the purpose of assessment.</p>
</div>

<div class="question-card">
  <h1>Question 15</h1>
  <p>The “Participation restriction” domain in ICF corresponds to:</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Physical impairments like paralysis</li>
    <li data-answer="correct">Challenges engaging in social or work roles</li>
    <li data-answer="wrong">Brain imaging findings</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Measuring Instruments and Their Limits</h2>
  <p>Functional assessment tools use ordinal scales, which may not allow for true mathematical operations like percentage changes. While <strong>Rasch analysis</strong> can convert ordinal to interval scales, many common tools lack this transformation. It’s important to recognize that adding or comparing scores directly can be misleading.</p>
</div>

<div class="question-card">
  <h1>Question 16</h1>
  <p>Why is adding ordinal scale scores from FA measures potentially problematic?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Ordinal scales don’t guarantee equal intervals between values</li>
    <li data-answer="wrong">Ordinal scales always inflate scores</li>
    <li data-answer="wrong">Ordinal scales use negative numbers</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Capacity vs. Performance & Data Collection Methods</h2>
  <p>FA distinguishes between <strong>capacity</strong> (what someone can do under ideal conditions) and <strong>performance</strong> (what they actually do in daily life). Methods include testing, clinician observation, and self- or proxy-report. Valid assessment considers context—environment and motivation significantly influence outcomes.</p>
</div>

<div class="question-card">
  <h1>Question 17</h1>
  <p>Which method measures capacity rather than performance?</p>
  <ul class="options" id="options">
    <li data-answer="correct">In-Clinic Task Testing</li>
    <li data-answer="wrong">Home behavior observation</li>
    <li data-answer="wrong">Proxy questionnaire</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Psychometric Properties of FA Instruments</h2>
  <p>To be useful for individuals, FA instruments need high reliability (≥0.90) and validity. Validity types include content, predictive, known-group, and construct validity, ensuring the instrument measures what it should. Instruments must also avoid floor/ceiling effects and maintain ecological validity—applicability to real-life situations.</p>
</div>

<div class="question-card">
  <h1>Question 18</h1>
  <p>What level of reliability is needed for making decisions about individual patients?</p>
  <ul class="options" id="options">
    <li data-answer="correct">0.90 or higher</li>
    <li data-answer="wrong">0.50–0.60</li>
    <li data-answer="wrong">Any reliability is OK if valid</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Uses and Patient Perspective</h2>
  <p>FA supports:</p>
  <ol>
    <li>Individual care: guiding admission, goal-setting (e.g., COPM, GAS), tracking progress.</li>
    <li>Program use: evaluation, benchmarking, accreditation, reimbursement reporting.</li>
    <li>Research: assessing treatment impact and describing recovery trajectories.</li>
  </ol>
  <p>Crucially, participation measures align best with life satisfaction. Instruments like GAS, COPM, and POPS integrate patient values, bridging the gap between clinician and patient perspectives.</p>
</div>

<div class="question-card">
  <h1>Question 19</h1>
  <p>Which type of FA measure tends to correlate most strongly with patient life satisfaction?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Participation measures (e.g., POPS)</li>
    <li data-answer="wrong">Impairment measures (e.g., GCS)</li>
    <li data-answer="wrong">Imaging-based measures</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Common FA Instruments Overview</h2>
  <p>The chapter reviews many tools:</p>
  <ol>
    <li><strong>Impairment:</strong> GCS.</li>
    <li><strong>Activity:</strong> Barthel Index, FIM (with FAM additions).</li>
    <li><strong>Participation:</strong> CHART, CIQ, POPS, PM‑PAC.</li>
    <li><strong>Cross‑cutting:</strong> LCFS/Rancho, DRS, MPAI, GOS‐E.</p>
  </ol>
  <p>A useful online resource is <strong>COMBI</strong>, which catalogues TBI-specific instruments and their psychometric profiles.</p>
</div>
<!-- END OF CHAPTER 16 HTML -->

<!-- START OF CHAPTER 17 HTML -->
<div class="explanation-card">
  <h1>Chapter 17: Life Expectancy After Traumatic Brain Injury</h1>
  <h2>Understanding Life Expectancy Terminology</h2>
  <p>Life expectancy reflects the <strong>average survival time for a group</strong>, not for an individual. Important distinctions include:</p>
  <ol>
    <li><strong>Survival time</strong>—how long someone lives after injury.</li>
    <li><strong>Median survival</strong>—the time at which half the group has died.</li>
    <li><strong>Standardized mortality ratio (SMR)</strong>—comparison of death rates to expected norms.</li>
  </ol>
  <p>Clinicians need these definitions to interpret data correctly and avoid overgeneralizing from group averages to individual patients.</p>
</div>

<div class="question-card">
  <h1>Question 20</h1>
  <p>What does life expectancy represent?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">The exact lifespan of an individual</li>
    <li data-answer="correct">Average survival of a comparable group</li>
    <li data-answer="wrong">Maximum possible lifespan</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Causes of Death: Short‑ and Long‑Term</h2>
  <p>In the short term, death is mainly due to <strong>the brain injury itself</strong>, followed by complications like pneumonia. Long-term, mortality from <strong>epilepsy, suicide, respiratory infections, and circulatory disease</strong> is elevated. For example, post‑traumatic epilepsy carries an SMR of ~24, and pneumonia deaths are 10× higher in immobile individuals.</p>
</div>

<div class="question-card">
  <h1>Question 21</h1>
  <p>Which long-term cause of death is disproportionately elevated after TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Skin cancer</li>
    <li data-answer="correct">Post‑traumatic epilepsy</li>
    <li data-answer="wrong">Appendicitis</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Impact of Disability on Life Expectancy</h2>
  <p>Life expectancy after TBI depends heavily on injury severity and disability level. For instance:</p>
  <ol>
    <li><strong>Severely disabled children/adolescents</strong> can lose ~40 years of life expectancy.</li>
    <li>An average reduction of ~7 years was found among TBI Model System participants.</li>
    <li>Those with extreme disability may have life expectancy reduced by half.</li>
  </ol>
  <p>Here, the degree of functional ability is the strongest determinant of lifespan.</p>
</div>

<div class="question-card">
  <h1>Question 22</h1>
  <p>Which group saw a ~40‑year reduction in life expectancy?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Children/adolescents with the most severe disabilities</li>
    <li data-answer="wrong">Elderly patients with moderate TBI</li>
    <li data-answer="wrong">Patients with mild TBI</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Key Predictors of Long‑Term Survival</h2>
  <p>Strong predictors include:</p>
  <ol>
    <li><strong>Mobility</strong>—nonambulatory individuals have ~4× higher mortality.</li>
    <li><strong>Feeding ability</strong>—lack of self-feeding predicts worse survival.</li>
    <li><strong>Age, sex, epilepsy, maladaptive behaviors</strong> also affect risk, though motor ability remains the biggest driver.</li>
  </ol>
</div>

<div class="question-card">
  <h1>Question 23</h1>
  <p>Which functional ability is the single strongest predictor of long‑term survival after TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Cognitive clarity</li>
    <li data-answer="correct">Mobility</li>
    <li data-answer="wrong">Vision</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Trajectory Over Time and Care Quality</h2>
  <p>Mortality risk declines after the first two years but then plateaus—the "healthy survivor" effect. Despite this, some decline functionally faster than uninjured peers.</p>
  <p>Quality of care matters—but cannot offset the impact of severe disability. Even with excellent care, life expectancy remains significantly reduced in profoundly disabled individuals.</p>
</div>

<div class="question-card">
  <h1>Question 24</h1>
  <p>What happens to mortality risk after two years post-TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">It continues rising linearly</li>
    <li data-answer="correct">It declines then stabilizes</li>
    <li data-answer="wrong">It immediately returns to normal</li>
  </ul>
</div>

<div class="explanation-card">
  <h2>Individual Prognosis vs. Group Statistics</h2>
  <p>It’s critical to distinguish between <strong>individual survival</strong> and <strong>group-based life expectancy</strong>. While group data suggest significant reductions, individual outcomes vary unpredictably. Using mortality tables adjusted for mobility, feeding status, and other factors allows more reasoned estimates than intuition alone.</p>
</div>
<!-- END OF CHAPTER 17 HTML -->


  <div class="placeholder" id="empty">Test</div>

</div>